Pharmaceuticals

With weeks to go before the Commission publishes its legislative proposals, members of the parliament’s ITRE committee are divided over how to secure the future of Europe’s most research intensive sector

EU health commissioner downplays concerns of ‘democratic deficiencies’ in the setup of HERA, as the European Parliament demands more transparency and a greater say in how the authority operates

AMR Action Fund will support biotechs working on later stages of clinical development, with the aim of delivering 2 - 4 new antibiotics by 2030